Authors: Decker, T Schneller, F Kronschnabl, M Dechow, T Lipford, GB Wagner, H Peschel, C

Citation: T. Decker et al., Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotype, EXP HEMATOL, 28(5), 2000, pp. 558-568

Authors: von Bubnoff, N Sandherr, M Schneller, F Peschel, C

Citation: N. Von Bubnoff et al., Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast, AM J CL ONC, 23(1), 2000, pp. 74-77

Authors: Decker, T Schneller, F Sparwasser, T Tretter, T Lipford, GB Wagner, H Peschel, C

Citation: T. Decker et al., Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells, BLOOD, 95(3), 2000, pp. 999-1006

Authors: Brass, U Tretter, T Schneller, F Schuler, M Huber, C Peschel, C

Citation: U. Brass et al., IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro, J INTERF CY, 19(4), 1999, pp. 335-343

Authors: Schuler, M Tretter, T Schneller, F Huber, C Peschel, C

Citation: M. Schuler et al., Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals, IMMUNOBIOL, 200(1), 1999, pp. 128-139

Authors: Schneller, F Schuler, M Schumacher, K Thaler, J Peschel, C Huber, C Aulitzky, W

Citation: F. Schneller et al., Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia - results of a phase-II trial, ANN HEMATOL, 77(5), 1998, pp. 225-229